Interestingly, loss of SATB1 expression is associated with a poor response to adjuvant chemotherapy in colorectal cancer [PMID: 24118100 (33)], indicating that the direction of the effect of SATB1 expression on drug response may be cancer type and/or therapy specific. Here, SATB1 is linked to cancer.